Research Inhaled cannabis could treat ocular hypertension, glaucoma: study The results show that smoking pot can produce up to a 16% reduction in eye pressure Nick LabaFebruary 11, 2022
The weed wire Preclinical results for InMed’s CBN glaucoma treatment show promise Studies showed CBN formulations reduced interocular pressure and protected retinal cells in the eye Nick LabaMay 27, 2020
Medical and Pharmaceutical Cannabinol (CBN) the main ingredient in potential treatments for glaucoma and a rare skin disease InMed Pharmaceuticals has initiated a clinical trial for its epidermolysis bullosa treatment, after regulatory approval in December Nick LabaJanuary 20, 2020